ArticleMarine drugs2024

Marine Cytotoxin Santacruzamate A Derivatives as Potent HDAC1-3 Inhibitors and Their Synergistic Anti-Leukemia Effects with Venetoclax.

Wanting Hao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.